Madison Clarke
The Johnson & Johnson COVID-19 vaccine is a viral vector vaccine that uses a modified adenovirus to carry the gene for the coronavirus spike protein into the body's cells. Unlike the mRNA vaccines from Pfizer and Moderna, which deliver genetic material directly to cells, the J&J vaccine uses a shell of a virus that causes the common cold but has been altered so it cannot replicate or cause illness. This Trojan horse method allows the immune system to develop antibodies to SARS-CoV-2 without being infected by the virus. The J&J vaccine has been shown to be effective in preventing COVID-19 infections and has offered high protection against hospitalisation and death.
| Characteristics | Values |
|---|---|
| Vaccine type | Viral vector vaccine |
| Virus used | Adenovirus |
| Spike protein used | Pre-fusion form of the SARS-CoV-2 spike protein |
| Genetic material | DNA |
| Efficacy | 66% effective at preventing moderate to severe Covid-19 |
| Doses | Single dose |
| Breakthrough infections | Lowest rate among all vaccines |
| Effectiveness against Delta variant | 76% effective in preventing Covid-19 infections |
| Effectiveness against Omicron variant | Unvaccinated people were 2.4 times more likely to get infected |
Explore related products
What You'll Learn
The J&J vaccine uses a viral vector approach
The Johnson & Johnson (J&J) COVID-19 vaccine is a viral vector vaccine that uses a replication-incompetent adenovirus vector platform. This means that it uses a modified and harmless version of a different virus, Adenovirus 26, as a "vector" to deliver the DNA gene sequence that encodes for the coronavirus spike protein.
The J&J vaccine is different from the Pfizer-BioNTech and Moderna vaccines, which are mRNA vaccines. mRNA vaccines use a new approach by delivering mRNA into our cells to provide the genetic instructions for our cells to temporarily make the coronavirus spike protein, triggering an immune response. In contrast, the J&J vaccine uses a "shell of a virus" to carry the genetic material into our cells. This "shell" is the adenovirus, which has been modified so that it can no longer replicate and cause illness.
Once the J&J vaccine enters the cells, the DNA encoding for the coronavirus spike protein is read by the cell and transcribed into mRNA. At this point, the J&J vaccine acts similarly to the mRNA vaccines. The mRNA contains the genetic instructions for the cell to make the spike protein, which triggers an immune response. The immune response causes the body to produce antibodies and activate T-cells to fight off what it perceives as an infection.
The J&J vaccine is a safe and effective option for COVID-19 vaccination. It continues to increase in efficacy after the initial two weeks, and immunogenicity data suggest that the immune response may continue to improve even after 28 days. The J&J vaccine does not alter our DNA or change our genetic code. The DNA and RNA quickly degrade in the human body and do not affect our chromosomes.
Mercury in Fish vs Vaccines: Which Has Higher Levels?
You may want to see also
Explore related products
It uses a modified adenovirus
The Johnson & Johnson COVID-19 vaccine uses a modified adenovirus. Adenoviruses are a group of common viruses that cause infections, like the common cold, but they can be modified to carry genetic instructions for cells. In the case of the Johnson & Johnson vaccine, the adenovirus is modified so that it can no longer replicate and cause sickness.
The use of viral vectors for gene transfer is a relatively simple idea. It involves inserting the desired genetic material into the viral genome, allowing one to take advantage of the virus's inherent ability to transduce cells for a therapeutic outcome. The Johnson & Johnson vaccine uses this "shell of a virus" to carry genetic material into the body's cells.
Adenovirus (Ad) vectors are widely recognised as having great potential by many applied virologists who wish to manipulate and use viral biology to achieve beneficial clinical outcomes. Adenoviruses are extensively characterised, modified, and employed for a variety of purposes. They are one of the most extensively studied and widely used viral vector systems, with human subgroup C Ads being the most extensively characterised.
Adenoviruses have been used to make changes to a virus's genome to decrease replication efficiency in human cells and render it harmless. This is done by modifying the fiber coat protein sequence to target the virus to more prevalent receptors in the vasculature. Adenoviruses are also known to interact with several different extracellular, intracellular, and membrane-bound innate immune sensing systems. Studies involving the manipulation of the Ad infectious cycle and the use of different mutants have shed light on the initiation mechanisms underlying Ad-induced immune responses.
The Polio Vaccine: A Historical Breakthrough
You may want to see also
Explore related products
The adenovirus carries the gene for the coronavirus spike protein
The Johnson & Johnson COVID-19 vaccine uses a viral vector approach, which is a "mashup" of two viruses. The J&J vaccine uses a "shell of a virus" to carry the genetic material into human cells. This "shell" is an adenovirus, which normally causes the common cold. However, the adenovirus has been modified so that it can no longer replicate and cause illness.
The adenovirus vector vaccine acts like a Trojan horse. Instead of soldiers jumping out, the adenovirus releases genes that encode the coronavirus's spike protein. The spike protein is essential for the SARS-CoV-2 virus to infect human cells. Without these spike proteins, the virus cannot enter human cells and replicate. The J&J vaccine uses the pre-fusion form of the spike protein, which is the version that binds to human cells and causes COVID-19 infection. By using this pre-fusion form, the vaccine trains the body to identify and fight the SARS-CoV-2 spike proteins as soon as they are introduced into the body.
The genetic material in the J&J vaccine is DNA, which is used by the body to make RNA, and then the spike protein of the coronavirus. The DNA and RNA quickly degrade in the body and do not affect human chromosomes. Once the cells make the spike protein, the immune system responds by producing T cells and antibodies to fight the virus. This immune response allows the body to recognize and respond quickly to a real SARS-CoV-2 infection.
British Airways Pilots: Vaccine Deaths or Coincidence?
You may want to see also
Explore related products
The vaccine prompts the body to produce the spike protein
The Johnson & Johnson COVID-19 vaccine is a viral vector vaccine that uses a "shell of a virus" to carry genetic material into human cells. The vaccine differs from mRNA vaccines such as those from Pfizer and Moderna, which deliver fat-covered bits of genetic material into cells. In contrast, the J&J vaccine uses an adenovirus, which usually causes the common cold, as its shell. This adenovirus has been modified so that it cannot replicate and cause illness.
The J&J vaccine contains DNA that the body uses to make RNA, which then becomes the spike protein of the coronavirus. This spike protein is essential for the virus to infect human cells. By producing this spike protein, the body can train itself to identify the SARS-CoV-2 spike proteins and fight off the virus. The DNA and RNA quickly degrade in the body and do not affect human chromosomes.
The J&J vaccine stood out for its convenience as a single dose and its lack of special refrigeration requirements. This flexibility appealed to people afraid of shots or those without easy access to healthcare services. The vaccine has been shown to be durable and effective, providing lasting immunity for at least six months. It was found to be 76% effective in preventing COVID-19 infections and 81% effective in preventing hospitalizations.
The J&J vaccine also continues to increase in efficacy over time. Immunogenicity data suggest that the immune response may improve even after 28 days. This extended efficacy has been referred to as "the gift that keeps on giving." The vaccine has been crucial in reducing hospitalizations and deaths, especially considering the rarity of the associated side effects.
The Chicken Pox Vaccine: Aborted Fetus Cells?
You may want to see also
Explore related products
The immune system learns to recognise the spike protein
The Johnson & Johnson COVID-19 vaccine uses a viral vector approach, which is a "mashup" of two viruses. The J&J vaccine uses an adenovirus—a type of virus that causes the common cold—which has been modified so it cannot replicate and cause illness. The gene for the coronavirus spike protein has been added to the adenovirus.
The SARS-CoV-2 spike protein is essential for the virus to infect human cells. Without these spike proteins, the virus cannot enter the cell and take over the cellular machinery to make more copies of itself. The J&J vaccine uses the pre-fusion form of the SARS-CoV-2 spike protein as the antigen of interest. This pre-fusion form is the version that would bind to human cells and cause COVID-19 infection.
The J&J vaccine works by prompting cells to produce the spike protein. Once the antigen is introduced into the body, the immune system works to neutralize and establish immunity to the antigen. The immune system learns to recognize the spike protein, so it can respond quickly to a real infection. The body raises an immune response with T cells and antibodies to that spike protein, allowing it to fight the virus if it is encountered in the future.
The J&J vaccine uses the pre-fusion spike protein conformation to train the body to identify the SARS-CoV-2 spike proteins and fight the virus as soon as it is introduced into the body. This training ensures that the spike protein does not come into contact with human cells when exposed to it naturally, introducing a preventative barricade at the very start of the infection mechanism.
Denmark Suspends COVID-19 Vaccines for Youths
You may want to see also
Frequently asked questions
Yes, the J&J vaccine uses the pre-fusion form of the SARS-CoV-2 spike protein as the antigen of interest.
The J&J vaccine is a viral vector vaccine that uses a "shell of a virus" or an adenovirus to carry genetic material into human cells.
The J&J vaccine uses the pre-fusion spike protein conformation to train the body to identify the SARS-CoV-2 spike proteins and fight the virus.
An adenovirus is a type of virus that causes the common cold and has been modified so it cannot replicate and cause illness.
The J&J vaccine is 66% effective at preventing moderate to severe Covid-19 and offers high protection against hospitalisation.
